Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000032111 | SCV002257799 | likely pathogenic | Propionic acidemia | 2023-06-22 | criteria provided, single submitter | clinical testing | Experimental studies have shown that this missense change affects PCCA function (PMID: 12385775). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PCCA protein function. ClinVar contains an entry for this variant (Variation ID: 38868). This variant is also known as 416T>C (Ile139Thr). This missense change has been observed in individual(s) with propionic Acidemia (PMID: 10101253, 11592820). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs202247815, gnomAD 0.003%). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 164 of the PCCA protein (p.Ile164Thr). |
Baylor Genetics | RCV000032111 | SCV004202844 | likely pathogenic | Propionic acidemia | 2023-10-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000032111 | SCV000055651 | not provided | Propionic acidemia | no assertion provided | literature only |